Cafepharma Today

May 15 2025 - FDA approves Amneal's self-administered migraine treatment
FDA approves Amneal's self-administered migraine treatment
VC firm reveals plan for 30K-square-foot biotech incubator space in New Jersey
Philips taps Nvidia to build AI model for MRI
FDA delays decision on Biohaven's rare disease drug filing, plans adcomm
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

A Faster Pathway to Drug Approvals
Motley Fool
Sunday, August 1, 2010 - 2:26pm
tags:
Europe, FDA, drug approvals, AMA, Eli Lilly, Takeda, Pfizer, Eisai, Epix
Teva: Canadian regulators clear Ratiopharm deal
Yahoo/AP
Sunday, August 1, 2010 - 2:24pm
tags:
Teva Pharmaceuticals, Ratiopharm, M&A
Sanofi-Aventis CEO Plays Cool on Genzyme
WSJ Online
Friday, July 30, 2010 - 11:43am
tags:
Pharma CEOs, Genzyme, M&A, Sanofi, Chris Viehbacher
Merck Ready to Play Let’s Make an (Emerging Markets) Deal
WSJ Online
Friday, July 30, 2010 - 11:42am
tags:
Merck, emerging markets, M&A, Brazil, China, India
Senate Committee OKs Pay-To-Delay Provision
Pharmalot
Friday, July 30, 2010 - 11:26am
tags:
pay-for-delay, generics
Astellas to shutter NY facilities, cut jobs
Fierce Pharma
Friday, July 30, 2010 - 11:24am
tags:
Astellas, layoffs
Amgen: On the Path to a Blockbuster
Motley Fool
Friday, July 30, 2010 - 11:23am
tags:
Prolia, Amgen, osteoporosis
Orexigen's Two-Drug Obesity Pill Cuts Hunger, Cravings, Weight in Study
Bloomberg
Friday, July 30, 2010 - 11:05am
tags:
Orexigen, obesity, Contrave, Vivus, Arena Pharmaceuticals
Jazz: Your FDA Panel Primer
Seeking Alpha
Friday, July 30, 2010 - 11:01am
tags:
Jazz Pharmaceuticals, FDA, advisory panels, fibromyalgia
Merck Still Struggles With Adult Hepatitis B Vaccine
Pharmalot
Friday, July 30, 2010 - 10:58am
tags:
Merck, hepatitis B, vaccines, Recombivax
Novo Nordisk, Lilly, Novartis Said to Bid for Ascendis Pharma
Bloomberg Businessweek
Friday, July 30, 2010 - 10:55am
tags:
Novo Nordisk, Eli Lilly, Novartis, Ascendis, M&A
Geron rallies as FDA green lights stem cell study
Marketwatch
Friday, July 30, 2010 - 10:52am
tags:
Geron, stem cells, FDA
FDA warning linked to Cubist drug
Bizjournals.com
Friday, July 30, 2010 - 10:47am
tags:
FDA, Cubist Pharmaceuticals, antibiotics, Cubicin
Merck profit drops 51%, adjusted net income rises
Marketwatch
Friday, July 30, 2010 - 10:45am
tags:
Merck, earnings
Sanofi-Aventis to Genzyme: Game On
Seeking Alpha
Friday, July 30, 2010 - 10:43am
tags:
Sanofi, Genzyme, M&A, AstraZeneca
Charles River, WuXi Make Mutual Decision To End Deal
WSJ Online
Friday, July 30, 2010 - 12:29am
tags:
Charles River Laboratories, WuXi PharmaTech, M&A
Amgen Q2 Beats, Driven by International Sales
Barron's
Friday, July 30, 2010 - 12:25am
tags:
Amgen, earnings
Is Abbott a Buy?
Motley Fool
Friday, July 30, 2010 - 12:23am
tags:
Abbott Laboratories, Humira, Solvay
Neurocrine Looks Well Positioned
Yahoo/AP
Friday, July 30, 2010 - 12:22am
tags:
Neurocrine, Abbott Laboratories, GSK, GnRH antagonists
Hospira plans big study for new Epogen biosimilar
Fierce Biotech
Thursday, July 29, 2010 - 3:24pm
tags:
Hospira, Epogen, biosimilars, generics, anemia

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.